NCT02658968 2024-01-16Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)Nordic NanovectorPhase 1 Completed18 enrolled 16 charts
NCT00103779 2014-12-18A Safety Study of SGN-40 in Patients With Non-Hodgkin's LymphomaSeagen Inc.Phase 1 Completed50 enrolled